Albert David Ltd.
Snapshot View

View in App

Prices View details >>

575.60 +23.00 ▲4.2%

30 September 2022, 04:01:00 PM
Volume: 13

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.albertdavidindia.com
Market Cap 328.50 Cr.
Enterprise Value(EV) 315.60 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 46.56 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 12.36 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 492.76 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.17 Calculated using Price: 575.60
Dividend Yield 1.56 Period Ending 2022-03
No. of Shares Subscribed 0.57 Cr. 5,707,162 Shares
FaceValue 10
Company Profile
Albert David was incorporated in the year 1938. The company is a part of Kothari group.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+4.16%
1 Week
+1.88%
1 Month
+5.95%
3 Month
+10.88%
6 Month
+6.39%
1 Year
-3.68%
2 Year
+30.64%
5 Year
+101.79%
10 Year
+397.49%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 14.67 14.96 41.80 9.98 5.33 13.44 8.85 9.48 13.46
Return on Capital Employed (%) 17.79 18.22 46.48 14.29 7.94 20.60 13.74 11.99 18.06
Return on Assets (%) 5.30 5.52 19.35 5.18 2.77 7.23 4.95 5.51 8.01

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 81 90 93 137 183 186 210 223 244 279
Non Curr. Liab. 42 59 14 8 9 15 20 27 26 20
Curr. Liab. 86 115 125 120 159 160 145 149 135 175
Minority Int.
Equity & Liab. 210 265 231 265 351 361 376 398 405 475
Non Curr. Assets 95 123 74 69 116 118 113 130 128 155
Curr. Assets 115 141 158 196 234 243 263 268 278 320
Misc. Exp. not W/O
Total Assets 210 265 231 265 351 361 376 398 405 475

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 291 322 323 295 290 317 321 247 314 326
Other Income 1 2 2 16 10 21 7 17 16 5
Total Income 291 324 325 311 300 339 328 265 329 331
Total Expenditure -258 -285 -291 -277 -275 -288 -290 -228 -273 -283
PBIDT 33 39 33 34 25 51 38 36 57 48
Interest -4 -3 -2 -1 -1 -1 -1 -1 -1 -1
Depreciation -11 -15 -9 -8 -8 -7 -8 -8 -9 -9
Taxation -6 -7 -15 -10 -6 -16 -10 -5 -12 -12
Exceptional Items 41
PAT 13 14 48 16 10 27 19 22 35 27
Adjusted EPS 22 24 84 28 17 47 34 39 62 47

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 20 21 28 68 20 30 32 30 37 40
Cash Fr. Inv. -9 -24 -9 -38 -37 -11 -19 -20 -39 -40
Cash Fr. Finan. -8 -2 -18 -18 7 -5 -17 -10 -2 -5
Net Change 3 -5 1 12 -10 14 -4 0 -4 -4
Cash & Cash Eqvt 15 9 10 22 -4 11 6 6 3 -1

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 61.16 61.16 61.16 61.25 61.25 61.35 61.64 61.96 61.99
Public 38.84 38.84 38.84 38.75 38.75 38.65 38.36 38.04 38.01
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 13 Sep 2022
Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 this is to inform you that the Board of Directors of the Company in their meeting held today i.e. 13th September 2022 has reconstituted the following Committees of the Board of Directors with immediate effect.A. Stakeholder Relationship and Grievance CommitteeSl. No. Name of Committee Member Position Category1 Mr. Hemal Kampani Chairman Non-Executive Independent Director2 Mr. Arun Kumar Kothari Member Executive Director3 Mrs. Prabhawati Devi Kothari Member Non-Executive Director4 Dr. Monjori Mitra Member Non-Executive Independent DirectorB. Corporate Social Responsibility CommitteeSl. No. Name of Committee Member Position Category1 Mr. Arun Kumar Kothari Chairman Executive Director2 Mrs. Prabhawati Devi Kothari Member Non-Executive Director3 Mr. Arindam Sarkar Member Non-Executive Independent Director4 Mr. S. G. Belapure Member Non-Executive Independent Director
Tue, 13 Sep 2022
Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 this is to inform you that the Board of Directors of the Company in their meeting held today i.e. 13th September 2022 has reconstituted the following Committees of the Board of Directors with immediate effect.A. Stakeholder Relationship and Grievance CommitteeSl. No. Name of Committee Member Position Category1 Mr. Hemal Kampani Chairman Non-Executive Independent Director2 Mr. Arun Kumar Kothari Member Executive Director3 Mrs. Prabhawati Devi Kothari Member Non-Executive Director4 Dr. Monjori Mitra Member Non-Executive Independent DirectorB. Corporate Social Responsibility CommitteeSl. No. Name of Committee Member Position Category1 Mr. Arun Kumar Kothari Chairman Executive Director2 Mrs. Prabhawati Devi Kothari Member Non-Executive Director3 Mr. Arindam Sarkar Member Non-Executive Independent Director4 Mr. S. G. Belapure Member Non-Executive Independent Director
Tue, 13 Sep 2022
Announcement under Regulation 30 (LODR)-Meeting Updates
Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 this is to inform you that the Board of Directors of the Company in their meeting held today i.e. 13th September 2022 has reconstituted the following Committees of the Board of Directors with immediate effect.A. Stakeholder Relationship and Grievance CommitteeSl. No. Name of Committee Member Position Category1 Mr. Hemal Kampani Chairman Non-Executive Independent Director2 Mr. Arun Kumar Kothari Member Executive Director3 Mrs. Prabhawati Devi Kothari Member Non-Executive Director4 Dr. Monjori Mitra Member Non-Executive Independent DirectorB. Corporate Social Responsibility CommitteeSl. No. Name of Committee Member Position Category1 Mr. Arun Kumar Kothari Chairman Executive Director2 Mrs. Prabhawati Devi Kothari Member Non-Executive Director3 Mr. Arindam Sarkar Member Non-Executive Independent Director4 Mr. S. G. Belapure Member Non-Executive Independent Director

Technical Scans View Details >>

Fri, 30 Sep 2022
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 949.00 +2.0%
Divi's Laboratories Ltd. 97,811.90 3,684.50 -0.2%
Cipla Ltd. 89,996.82 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. 52,506.43 1,551.40 +0.3%
Abbott India Ltd. 40,438.70 19,030.60 -0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 36.17 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 50.01 19,030.60 -0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-06 4.19 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-06 13.56 19,030.60 -0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 19,030.60 -0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 19,030.60 -0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 949.00 +2.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,684.50 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,115.20 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,333.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,370.00 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,551.40 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 19,030.60 -0.8%

FAQ's On Albert David Ltd.

What is Albert David share price?
Can I buy Albert David shares now?
What is the Dividend Yield of Albert David?
What is the Market Cap of Albert David?
What are the key metrics to analyse Albert David?
What is the 52 Week High and Low of Albert David?
What is the trend of Albert David share price?